Wednesday, 30 October 2019

FDA approves multiple sclerosis drug from Biogen and Alkermes

Biogen Inc and partner Alkermes Plc said on Wednesday that the U.S. Food and Drug Administration approved their oral drug to treat multiple sclerosis.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)